Calling all MDMA members! Join Medcrypt for a webinar on Dec 10.
From SBOMs to risk management, this session will cover key insights to help manufacturers stay ahead of regulatory expectations and protect patients.
Members can register here: members.medicaldevices.org/e…
In May, Medcrypt CEO Mike Kijewski was invited to the White House to discuss the critical issue of healthcare cybersecurity. Mike met with representatives from the NSC, CISA, HHS, DHS, and other key government agencies.
Read more: medcrypt.com/blog/medcrypt-a…
With Medcrypt's Helm, medical device manufacturers can stay ahead of potential threats and ensure the safety of their devices.
Read the full case study to learn how Helm is setting the standard for SBOM and Vulnerability Management: medcrypt.com/blog/case-study…
On April 18, 2024, MedISAO @isao_med and the @US_FDA signed a renewed MOU, reinforcing their ongoing collaboration and emphasizing the critical need to strengthen the #cybersecurity posture of the medical device industry.
Read the full announcement: prunderground.com/u-s-food-a…
Join us on May 22nd for an exclusive Medical Device Manufacturers Association @medicaldevices member-only webinar, "Ways to Succeed with the FDA Cybersecurity Guidance"
Don't miss this opportunity. MDMA members can register now: medicaldevices.org/events/Ev…
Medcrypt is proud sponsor of the Medical Extended Reality Summit #MXR2024 hosted by @MDIConline! We're looking forward to connecting with industry leaders and regulators about #healthtech.
Come by Medcrypt's booth April 16-17, 2024. Register here: mdic.org/event/mdic-medical-…
FDA is issuing deficiency letters- why should you care?
In this 4-part blog series, discover how receiving a deficiency letter impacts the work of your product engineers, regulatory affairs professionals, and the c-suite. Read part one to get started: medcrypt.com/blog/fda-is-iss…
The webinar recording for Medcrypt's webinar, Vulnerability Lifecycle Management: Check Yourself Before You Wreck Yourself, is now available: medcrypt.com/private/webinar…
In a recent interview with David Leichner of @AuthorityMgzine, CEO @mikekijewski discusses the significance of the government’s recent shift in focus toward Medical Device Security through new regulations and initiatives.
Read Mike’s full interview: bit.ly/42bfJkA
Medcrypt is excited to announce the addition of Taylor Lehmann to our Board of Directors! Taylor will play a pivotal role in supporting Medcrypt’s governance efforts, strategic initiatives, and championing investor interests.
Read the full press release: prn.to/3uN9syW
In a new article posted to Forbes, Medcrypt CEO Mike Kijewski discusses how healthtech companies can best prepare for the FDA’s impending RTA guidelines — as well as the importance of cybersecurity to the industry.
Read Mike’s full article on Forbes here: bit.ly/3OSQpJV
Medcrypt is proud to announce a brand new partnership with NetRise, the company providing visibility into the world’s XIoT security problems, to address critical cybersecurity challenges in the healthcare industry.
View the full press release below:
prn.to/3P4ww3Q
In a recent interview with Medtech Insight, Medcrypt's Naomi Schwartz gives her view on how the FDA eSTAR requirements that launch on October 1st will push the industry as a whole in a positive direction.
Read Naomi's full interview here: bit.ly/3OC2C5z
Tomorrow at 10AM PT/1PM ET, join MedCrypt's Cynthia Peralta for episode 2 of our Encryption, Key Management & PKI webinar series. This episode will focus on Key Lifecycle Management and best practices regarding cryptographic keys.
Register Here: bit.ly/3oYNoyO
MedCrypt's Mike Kijewski & Naomi Schwartz are featured in an article from SC Media about the FDA's recent Refuse to Accept guidelines and what manufacturers can expect from the FDA going forward.
Read more here: bit.ly/410CvtS
For the 4th and final part of our RTA blog series, we'll look at the required documentation you will need to generate & maintain as a part of your FDA regulatory submission.
Read here: medcryptnews.medium.com/fda-…
On March 29th, the FDA announced that they will soon begin rejecting medical devices that do not meet minimum cybersecurity standards. Manufacturers who do not meet standards will run the risk of product rejection.
@healthinfosec goes into further detail:bit.ly/3ZJofUS
(1/4) Over the next 4 days, MedCrypt is breaking down the key concepts of the FDA Refuse to Accept (RTA) guidance in a series of blogs posts
Today's message: build devices to be Secure by Design.
Read more and follow us to view the rest of the series: medium.com/medcrypt/fda-cybe…
On March 8th, MedCrypt's Axel Wirth and Naomi Schwartz discussed the regulatory implications of President Biden's newly signed omnibus bill on the medical device manufacturing industry. Missed this webinar? Watch the full recording here: bit.ly/3mXBl3c